CG Oncology, Inc. Common stockCGONNASDAQ
Loading
EV to Sales: Discounted ValuationCompressed
Percentile Rank25
3Y CAGR-60.3%
Year-over-Year Change
Enterprise value to sales ratio
3Y CAGR
-60.3%/yr
Annual compound
Percentile
P25
Within normal range
vs 3Y Ago
0.1x
Contraction
Streak
3 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 788.16 | -41.5% |
| 2024 | 1348.18 | -88.9% |
| 2023 | 12106.05 | -3.8% |
| 2022 | 12589.90 | +5248.0% |
| 2021 | 235.41 | - |